Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2013 1
2014 1
2016 2
2018 2
2019 2
2020 2
2021 3
2022 4
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Natural Killer Cell-Based Immunotherapy against Glioblastoma.
Morimoto T, Nakazawa T, Maeoka R, Nakagawa I, Tsujimura T, Matsuda R. Morimoto T, et al. Among authors: nakazawa t. Int J Mol Sci. 2023 Jan 20;24(3):2111. doi: 10.3390/ijms24032111. Int J Mol Sci. 2023. PMID: 36768432 Free PMC article. Review.
Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance.
Maeoka R, Ouji Y, Nakazawa T, Matsuda R, Morimoto T, Yokoyama S, Yamada S, Nishimura F, Nakagawa I, Park YS, Yoshikawa M, Nakase H. Maeoka R, et al. Among authors: nakazawa t. Biomed Pharmacother. 2023 Oct;166:115296. doi: 10.1016/j.biopha.2023.115296. Epub 2023 Aug 7. Biomed Pharmacother. 2023. PMID: 37557011 Free article.
Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors.
Nakazawa T, Morimoto T, Maeoka R, Matsuda R, Nakamura M, Nishimura F, Yamada S, Nakagawa I, Park YS, Nakase H, Tsujimura T. Nakazawa T, et al. Regen Ther. 2022 Jul 21;21:185-191. doi: 10.1016/j.reth.2022.07.001. eCollection 2022 Dec. Regen Ther. 2022. PMID: 35919498 Free PMC article.
Therapeutic Anti-KIR Antibody of 1-7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom.
Maeoka R, Nakazawa T, Matsuda R, Morimoto T, Shida Y, Yamada S, Nishimura F, Nakamura M, Nakagawa I, Park YS, Tsujimura T, Nakase H. Maeoka R, et al. Among authors: nakazawa t. Int J Mol Sci. 2023 Sep 16;24(18):14183. doi: 10.3390/ijms241814183. Int J Mol Sci. 2023. PMID: 37762486 Free PMC article.
30 results